Management of Hepatic Encephalopathy in the Hospital

Slides:



Advertisements
Similar presentations
Learning objectives To understand the pathophysiologic basis for vasoactive therapies for HRS To become familiar with the diagnostic criteria for HRS To.
Advertisements

HEPATIC FAILURE TITO A. GALLA. HEALTHY LIVER LIVER FUNCTION  METABOLISM  DETOXIFICATION PROCESS  PROTEIN SYNTHESIS  MANUFACTURE OF CLOTTING FACTOR.
Approach to a patient with jaundice
Intern Basics- Part II Jacobi medical Center. Falls Assess the patient after the fall Assess the patient after the fall Witnessed or not Witnessed or.
Chronic Liver Disease Simon Lynes. Definition Progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
Hepatitis web study H EPATITIS C O NLINE C OURSE Charles Landis, MD, PhD Assistant Professor of Medicine Division of Gastroenterology and Hepatology University.
Acute Liver Failure in the USA: Results of the US ALF Study Group William M. Lee, MD Meredith Mosle Distinguished Professor in Liver Disease University.
Journal club April 2010 Dr Aucamp Dr Buchel Rifaximin treatment in hepatic encephalopathy.
Pam Charity, MD Cathryn Caton, MD, MS.  Define pneumonia  Review criteria for diagnosis  Review criteria for admission  Review treatment options.
A Young Male With Idiopathic Hepatic Encephalopathy And A Necrotic Lower Extremity Evan D. Schmitz, M.D. Pulmonary & Critical Care Fellow Carl T. Hayden.
HEPATIC ENCEPHALOPATHY Dr. Bindu Mohandas M-5 unit.
Progress in Diagnosing and Treating Clostridium difficile in IBD patients Alan C. Moss MD, FEBG, FACG, AGAF Associate Professor of Medicine Director of.
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Alcoholic hepatitis Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Lenny Noronha, MD September 11, 2013.
1 Tolvaptan for the Treatment of Hyponatremia Aliza Thompson, MD Medical Officer Cardiovascular and Renal Drugs Advisory Committee Meeting June 25, 2008.
By: Michelle Russell Case Study Presentation NUR 4216L
1 Hepatitis B Treatment Dr R.V.S.N.Sarma., M.D., Consultant Physician & Chest Specialist.
HSV-Induced Acute Liver Failure: Treat First…..Diagnose Later? HSV-Induced Acute Liver Failure: Treat First…..Diagnose Later? Wiley D. Truss MD, MPH and.
HEPATO renal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine.
Clinical Approach to Patients Tanarat Choon-ngarm MD.
AMMONIA LEVELS & HEPATIC ENCEPHALOPATHY
Hepatorenal Syndrome Dr Allister J Grant Leicester Liver Unit
Creatinine (mg/dL) MonthsWeeks Therapeutic paracentesis Cefotaxime Type-2 HRSType-1 HRS Encephalopathy Jaundice CLINICAL TYPES.
Fact The evidence base for most of what we do in intensive care is rather poor.
Patient presenting with altered mental status
Iatrogenic Anemia in the ICU Anh Nguyen, MD, MPH, PGY2.
Paracentesis and Mortality in U.S. Hospitals José L. González, MD Wednesday, June 25 th, 2014Journal Club.
Hepatic encephalopathy/ Portal-systemic encephalopathy /hepatic coma
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division, Department of Medicine in King Saud University.
How to Analyze Therapy in the Medical Literature (part 2)
Using procalcitonin to care for hospitalized patients Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Division of Hospital Medicine July 22, 2015.
Anemia in the Hospitalized Elderly Hospitalist Best Practice J Rush Pierce Jr, MD, MPH February 29, 2012.
Clinical Assessment of Liver Toxicity Due to Telithromycin (Ketek®)
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
Acute On Chronic Liver Failure- Evolution of Concept 23 October 2015.
Hepatic Encephalopathy
Complications of Liver Cirrhosis
Copenhagen University Hospital Rigshospitalet, Denmark
Community Acquired Pneumonia (CAP)
Alcoholic Hepatitis Miriam Nojan PGY-2 April 2016.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Clinicaloptions.com/hepatitis HALT-C: Long-term Maintenance Peginterferon alfa-2a Slideset on: Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis.
Definition  Is a chronic disease characterized by scaring and necrotic tissue replaced by fibrotic tissue. Resulting in hepatic insufficiency and portal.
Hepatic Encephalopathy Iradj Maleki MD Mazandaran University of Medical Sciences Gut and Liver Research Center
INTERNAL MEDICINE BENJAMIN YIP 4/13/16 Mini Lecture: Hepatorenal Syndrome.
CIRRHOSIS MANAGEMENT FOR HOSPITALISTS Madhav Devani 6/7/16.
Barjesh Chander Sharma, MD, DM 1, Praveen Sharma, MD, DM 2, Manish Kumar Lunia, MD 1, Siddharth Srivastava, MD, DM 1, Rohit Goyal, MD, DM 1 and S.K. Sarin,
Randomized, Double-Blind, Controlled Study of Glycerol Phenylbutyrate in Hepatic Encephalopathy HEPATOLOGY 2014;59: 전임의 1 년차 신재령.
Liver Disease tutoring Part 1
Liver Disease tutoring Part 2
Copenhagen University Hospital Rigshospitalet, Denmark
Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure R1 김형오 / Prof. 심재준.
ACUTE LIVER FAILURE Acute liver failure is defined as the rapid development of hepatocellular dysfunction (WITHIN 8 WEEKS OF DISEASE ONSET), specifically.
L-Ornithine L-Aspartate in Bouts of Overt Hepatic Encephalopathy
The case FOR UDCA in PSC Aparna Goel, MD
DIAGNOSIS OF CIRRHOSIS
Multiple factors can predispose to decompensation in a patient with cirrhosis. Risk factors for decompensation include: Bleeding Infection Alcohol.
Hepatic Encephalopathy protocol - EMB review
2010/10/14 Presented by R4 謝岳哲 Supervisor VS 薛承君 Moderator VS 黃集仁
COMPLICATIONS OF CIRRHOSIS
Altered mental status in children
History 56 y/o male from Cuba newly diagnosed with hepatitis C genotype 2b in Jan 2008 No symptoms of decompensation.
Management of Clostridium Difficile Infection
Current Controversies and Advances in Hepatorenal Syndrome
New assessment of hepatic encephalopathy
Acute Liver.
Internal medicine L-5 Hepatic Encephalopathy
Acute Liver.
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Presentation transcript:

Management of Hepatic Encephalopathy in the Hospital Hospitalist Best Practice J Rush Pierce Jr, MD, MPH May 21, 2014

Management of Hepatic Encephalopathy in the Hospital Case Hx: 45 year old man with cirrhosis and ascites adm with 2 days of confusion. On lactulose for 1 year, wife doesn’t know if compliant. Wife says no fever, abd pain, cough, diarrhea. PE: 100/60, 72, afebrile. Sleepy but arousable. Spiders, jaundice, ascites, edema, 3+ reflexes Lab: WBC = 8,000, H/H = 11.8/34, plts = 70K. Na = 129, K = 3.4, Cl = 103, HCO3 = 21; BUN = 7, creat = 0.9. INR = 2.5, bili = 3.9, ALT/AST sl high. NH4 = 65. CXR and UA neg. 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Clinical questions Does this patient have hepatic encephalopathy? Should I order a CT scan of head? Should I do a diagnostic paracentesis to exclude SBP? Where should this patient be admitted? Will initial therapy be lactulose, rifaximin, or both? 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Classification of HE Source: 11th World Congress of Gastroenterology, 1998 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Acute hepatic failure and HE - Special considerations Predicts urgency for transplant At high risk for cerebral edema (70% for Grade IV) Benefit from specific treatments of cerebral edema More likely to benefit from ICU stay 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Diagnosis of HE Identify underlying liver disease Acute with severe transaminitis Chronic - portal HTN Ascertain neuropsychiatric sxs Sleep disturbance, alteration in level of consciousness, confusion Elicit neurologic signs Asterixis, hyperreflexia, clonus, +Babinski Exclude other causes 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

West Haven Clinical Severity Grades of HE 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Pierce’s simplification of West Haven Criteria Grade 0 = normal Grade 1 = alert but squirrely Grade 2= drowsy but awake Grade 3 = asleep but arousable Grade 4 = asleep and unarousable 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Asterixis https://www.youtube.com/watch?v=Or65nOrcz1A Also seen in: Uremia Severe CO2 retention Dilation toxicity Nodding off Source: Adams and Victor’s Principles of Neurology, Ch 6 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Excluding other causes Source: J Investig Med 2013;61:695 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Serum NH4 and diagnosing HE Source: J Hepatology 2003;38:441 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Serum NH4 and following response to therapy of HE Source: J Hepatology 2003;38:441 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

HE management algorithm Hemodynamic stabilization Detect and treat precipitants Lower blood ammonia Treat cerebral edema, if present Manage hyponatremia Source: Curr Treat Options Neurol 2014;16:297 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Identify and treat precipitating events Source: Clin Liver Dis 2012;16:73–89 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Dietary recommendations for HE Source: Hepatology 2013:58:325 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Predicting lactulose failure Source: European J Gastro Hepatology 2010, 22:526 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Drug treatment of HE Lactulose, Lactilol 2004 meta-analysis – superior to placebo but dop not improve survival When only high quality studies included, no effect Widely used in practice, recommended as first line rx Neomycin, metronidazole RCT: neomycin vs placebo – no difference Metonidazole, vancomyin – no RCT 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Treatment of HE - Rifaximin Source: World J Gastroenterol 2012;18:767 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Treatment of HE - Rifaximin 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

RCT – Rifaximin + lactulose vs lactulose Blinded prospective RCT, one center in New Delhi, 10/2010 – 09/2011, no drug sponsorship; Inclusion: adults, cirrhosis and overt HE Exclusion: creat > 1.5, active EtOH in 4 wks, HCC, psych illness, or major comorbidities All pts had rx of underlying precipitating illness Lactulose + rifaximin vs. lactulose + placebo; lactulose titrated to 2 – 3 stools/day All meds through NG tube Followed to discharge or death Source: Am J Gastroenterol 2013;108:1458 05/21/2014

Management of Hepatic Encephalopathy in the Hospital Source: Am J Gastroenterol 2013;108:1458 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Main findings There was a significant decrease in mortality after treatment with lactulose plus rifaximin vs. lactulose and placebo (23.8 % vs. 49.1 % , P < 0.05). [ARR = 25.3%, NNT = 4) No diff in side effects (diarrhea, abd pain) Pts who did not respond in each group had higher baseline total WBC (7742 vs 6058) Sepsis related deaths higher in lactulose + placebo group (17 vs 7) Source: Am J Gastroenterol 2013;108:1458 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital Hyponatremia in HE Source: J Hospital Med 2012;7:S14 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Mayo Clinic recommendations Source: Mayo Clin Proc. 2014;89(2):241 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Mayo Clinic recs (contd) Source: Mayo Clin Proc. 2014;89(2):241 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Mayo Clinic recs (contd) Source: Mayo Clin Proc. 2014;89(2):241 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Advice on discharge (Expert opinion) Home on lactulose All pts with Childs B/C Childs A and isolated episode, do test sev weeks after discharge Driving 18 MVA’s in 167 cirrhotic patients in 1 yr In car driving test Source: Mayo Clin Proc. 2014;89(2):241 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Review of clinical questions Does this patient have hepatic encephalopathy? Should I order a CT scan of head? Should I do a diagnostic paracentesis to exclude SBP? Where should this patient be admitted? Will initial therapy be lactulose, rifaximin, or both? 05/21/2014 Management of Hepatic Encephalopathy in the Hospital

Management of Hepatic Encephalopathy in the Hospital System Questions Should we grade HE? Should everyone with HE get a paracentesis? When should we use rifaximin? Would an HE care plan be useful? 05/21/2014 Management of Hepatic Encephalopathy in the Hospital